Chinook Logo.png
Chinook Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
April 07, 2021 16:05 ET | Chinook Therapeutics, Inc.
SEATTLE, April 07, 2021 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines...
logo_NextCure.jpg
NextCure to Present at the 20th Annual Needham Virtual Healthcare Conference
April 07, 2021 16:05 ET | NextCure
BELTSVILLE, Md., April 07, 2021 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class...
Prothena_RGB_fullcolor.jpg
Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 07, 2021 16:05 ET | Prothena Corporation plc
DUBLIN, Ireland, April 07, 2021 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with expertise in protein dysregulation and a pipeline of investigational...
catbio_logo_small2.jpg
Catalyst Biosciences to Present at the 20th Annual Needham Virtual Healthcare Conference
April 07, 2021 16:05 ET | Catalyst Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., April 07, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that members of its executive management team will present a corporate...
TTM Logo with Tagline 09-06-07.jpg
TTM Technologies, Inc. To Conduct First Quarter FY 2021 Conference Call April 28th, 2021
April 07, 2021 16:05 ET | TTM Technologies
SANTA ANA, Calif., April 07, 2021 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ:TTMI) will host a conference call on Wednesday, April 28th, at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time to...
TBIO.jpg
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
April 07, 2021 16:05 ET | Translate Bio, Inc.
LEXINGTON, Mass., April 07, 2021 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative...
topbuild_logo.png
TopBuild Acquires Creative Conservation
April 07, 2021 16:05 ET | TopBuild Corp.
Residential and Light Commercial Insulation $7.4 Million Annual Revenue DAYTONA BEACH, Fla., April 07, 2021 (GLOBE NEWSWIRE) -- TopBuild Corp. (NYSE:BLD) a leading installer and distributor of...
logoF_HORZ_SearchMin2c.jpg
Search Minerals Announces Closing of $2,520,000 Flow-Through Private Placement
April 07, 2021 16:02 ET | Search Minerals Inc
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, April 07, 2021 (GLOBE NEWSWIRE) -- Search Minerals Inc. (TSXV: SMY)...
Cara Therapeutics Logo
Cara Therapeutics to Present at the 20th Annual Needham Healthcare Conference
April 07, 2021 16:01 ET | Cara Therapeutics, Inc.
STAMFORD, Conn., April 07, 2021 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
Strongbridge Biopharma logo
Strongbridge Biopharma plc Announces Publication of Diabetes Subgroup Analysis from Phase 3 SONICS Study of RECORLEV® (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome in Frontiers in Endocrinology
April 07, 2021 16:01 ET | Strongbridge Biopharma plc
RECORLEV® (levoketoconazole) Treatment Demonstrates Clinically Meaningful Improvements in Cortisol Control and Clinical Benefit in Patients with Cushing’s Syndrome and Comorbid Diabetes Mellitus ...